A Selective Mineralocorticoid Receptor Blocker, Esaxerenone, Attenuates Vascular Dysfunction in Diabetic C57BL/6 MiceUugantsetseg Munkhjargal, Masataka Sata, Tomomi Matsuura et al.|Journal of Atherosclerosis and Thrombosis|2022Cited by 20
Inhibition of S1P Receptor 2 Attenuates Endothelial Dysfunction and Inhibits Atherogenesis in Apolipoprotein E-Deficient MiceByambasuren Ganbaatar, Masataka Sata|Journal of Atherosclerosis and Thrombosis|2020Cited by 14
Esaxerenone, a selective mineralocorticoid receptor blocker, improves insulin sensitivity in mice consuming high-fat dietOyunbileg Bavuu, Masataka Sata, Daiju Fukuda et al.|European Journal of Pharmacology|2022Cited by 6